Saturday, June 23, 2012 8:53:58 AM
"We were pleased with the Friday, June 8, meeting with the FDA. At the meeting we addressed the application of the technology to support our menstrual pain medical claim for Allay.
Dr. Kenneth McLeod, our consulting biophysics expert, made the technical presentation. Dr. McLeod received his PhD from MIT in electrical engineering, with a dissertation focused on electrophysiological properties of living tissue, and has worked in the field of bioelectromagnetics for more than 30 years. He is currently Director of the Clinical Science and Engineering Research Center at Binghamton University where the research is largely focused on functional disorders (such as chronic pain) and interventions to address these disorders. BioElectronics’ Chairman, Dr. Richard Staelin, is a mathematician and statistician, and was in attendance to support the clinical data analysis. Andrew Whelan was also in attendance at the meeting."
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM